Allogene Therapeutics Soars with Strong Market Close at 2.65, Up 1.15
☀️Trending News Allogene Therapeutics ($NASDAQ:ALLO) Inc. is a biotechnology company that specializes in developing innovative allogeneic CAR T cell therapies [...]
Allogene Therapeutics Stock Intrinsic Value – Allogene Therapeutics Reorganizes Pipeline Plans
🌥️Trending News Allogene Therapeutics ($NASDAQ:ALLO) is a clinical-stage biotechnology company that specializes in the development of allogeneic CAR T cell [...]
B. Riley Increases Q3 2023 Earnings Estimates for Allogene Therapeutics
🌥️Trending News B. Riley's equities research analysts have recently revised their Q3 2023 earnings estimates for Allogene Therapeutics ($NASDAQ:ALLO), a [...]
Virtu Financial LLC Invests in Allogene Therapeutics, in Q1
🌥️Trending News Allogene Therapeutics ($NASDAQ:ALLO), Inc. is a publicly traded biotechnology company focused on developing allogeneic, or donor-derived, therapies to [...]
Allogene Therapeutics Begins Search for New CFO Following Eric Schmidt’s Departure
🌥️Trending News Allogene Therapeutics ($NASDAQ:ALLO), a biopharmaceutical company dedicated to transforming the lives of patients with cancer and other serious [...]
CI Investments Increases Holdings in Allogene Therapeutics, Inc
🌥️Trending News Allogene Therapeutics ($NASDAQ:ALLO), Inc. is a clinical-stage biopharmaceutical company leading the next wave of cell therapy. The company [...]
Allogene Therapeutics Stock Gains 2.09% in a Week, Receives Bullish Score from InvestorsObserver
Trending News ☀️ Allogene Therapeutics ($NASDAQ:ALLO) Inc. (ALLO) has seen its stock surge by 2.09% in the past week, prompting [...]
Allogene Therapeutics Reports Unexpectedly High Revenue Despite Missing Earnings Estimate
Trending News ☀️ Allogene Therapeutics ($NASDAQ:ALLO), a biopharmaceutical company focused on developing allogeneic CAR T cell therapies for the treatment [...]
Allogene Therapeutics Sees Long-Term Potential Despite Short-Term Losses of -6.90% Over One Month
Trending News ☀️ Allogene Therapeutics ($NASDAQ:ALLO) Inc. is a publicly traded biotechnology company located in California. Recently, the company's stock [...]
Allogene Therapeutics Unveils Dagger™ Platform, Shaping the Future of AlloCAR T™ Technology.
Trending News 🌥️ Allogene Therapeutics ($NASDAQ:ALLO), a clinical-stage biotechnology company focused on developing next-generation allogeneic chimeric antigen receptor (CAR) T [...]
